Aug 2026· Cell Reports· Vol 45 9, pp.
117907
· 0 citations· 67 references
Medicine
TL;DR
Findings link macrophage metabolic remodeling to a pro-senescent secreted pathway and suggest a locally delivered strategy for OA, which reduces NEDD4-dependent ubiquitination and stabilizes THBS1 protein.
Abstract
Macrophages contribute to osteoarthritis (OA) pathogenesis, but how specific macrophage states influence chondrocyte senescence remains unclear. Using single-cell RNA sequencing of naturally aged mouse joints, we identified a PTGS2-high macrophage subset associated with joint senescence. In a surgically induced OA model, lineage tracing revealed a marked increase of these macrophages, and their selective depletion using a diphtheria toxin receptor-based mouse model attenuated cartilage senescence and disease progression. PTGS2+ macrophage-derived THBS1 promoted chondrocyte senescence through SDC4-associated pericellular interactions and, at least in part, TGF-β-dependent signaling. Macrophage-specific deletion of Thbs1 reduced chondrocyte senescence markers and attenuated OA-like degeneration. Mechanistically, elevated glycolytic lactate enhanced THBS1 lactylation at lysine 262 (K262), which reduces NEDD4-dependent ubiquitination and stabilizes THBS1 protein. Intra-articular targeting of PTGS2-high macrophages attenuated chondrocyte senescence and OA progression. These findings link macrophage metabolic remodeling to a pro-senescent secreted pathway and suggest a locally delivered strategy for OA.
BMSCs-Exos significantly mitigated IL-1β-induced chondrocyte senescence-like changes, apoptosis, SASP, and ECM degradation, as evidenced by the reversal of IL-1β-induced suppression of anabolic genes SOX9, COL2, ACAN and elevated catabolic gene MMP13.
Xiao-Dong Mao, Guo-Liang Che, Mi-Mi Zhang et al.· Journal of Cellular Biochemi...· 0 citations
NP-B2M provides a biocompatible, precisely targeted, long-acting platform that mimics exercise benefits, offering promising translational potential as a precision therapeutic strategy for immobile elderly OA patients.
Yu-Ting Cao, A. Lao, Shi-Jie Zhu et al.· Journal of Orthopaedic Trans...· 1 citation
These findings identify age-associated loss of GPR81 as a driver of vascular metabolic dysfunction and cellular senescence and establish pharmacological GPR81 activation as a promising therapeutic strategy for preserving vascular homeostasis and mitigating age-associated cardiovascular disease.
Yu-Lun Wu, Hamsa Vardini Senthil Kumar, Sai Harsha Bhamidipati et al.· bioRxiv· 0 citations
Autophagy dysfunction and senescence are established drivers of aging, but their potential interaction remains poorly understood. Here we show that age-related decline of chaperone-mediated autophagy (CMA), a pathway for selective lysosomal protein degradation, changes senescent cell properties and impairs their immune...
Rebecca Sereda, Kristen Lindenau, Antonio Díaz et al.· Nature Aging· 1 citation
Benign prostatic hyperplasia (BPH) is a common age-associated disease whose prevalence rises sharply with advancing age. Therapeutic responses to 5α-reductase inhibitors (5-ARIs) in BPH are heterogeneous and may ultimately culminate in the need for surgery; however, the mechanisms that permit disease progression during...
Zheng Li, Zhe-Nan Zhang, Qian-Cheng Zhao et al.· Experimental and Molecular M...· 0 citations
Chondrocyte hypertrophy is a key hallmark of osteoarthritis (OA) that drives a multitude of whole-joint disease processes. There are no approved disease-modifying pharmaceuticals in clinical use, emphasising the urgent need for innovative therapeutics. Screening of a focussed chemical library using a novel in vitro pla...
Leah M. Wells, Jacob A. C. Keen, Aikta Sharma et al.· Bone Research· 0 citations
We use cookies to run the site and, with your consent, for analytics and to show ads.
See our Cookie Policy.